The Arena Group Holdings, Inc. (AREN) Dividend History

Company News

• Beasley Broadcast And 2 Other Stocks Under $3 Insiders Are Buying

  The Dow Jones index closed lower by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. EMCORE The Trade: EMCORE Corporation (NASDAQ: EMKR) 10% owner Constantinos Christofilis acquired a total of 4,851,568 shares an average price of $0.36. ...

  Benzinga

  Featured Companies: BBGI
• Arena Group’s stock plummets over 30% after losing rights to Sports Illustrated

  Shares of Arena Group Holdings Inc. dropped more than 30% on Friday after the ailing media company lost its license to publish Sports Illustrated and the union for the famed publication said "possibly all" union-member staff could be laid off as a result.

  MarketWatch
• Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion. Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96. Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update. Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22. Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193. NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio. QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563. Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3. Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51. Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025. Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific. Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance. LendingTree, Inc. (NASDAQ: TREE) ...

  Benzinga

  Featured Companies: ARDX AVDL BA BCRX BFLY BNZI BSGM CMC CROX CYCC DVAX ELEV FSLY IVP MTC NAK NKTX OPK PACB PRAX PRTA RGNX RXST SGD SHPH SPR STSS STTK TREE UPC UPWK VERO WWW ZJYL
• Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

  Shares of LumiraDx Limited (NASDAQ: LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from trading on Nasdaq at the open of business on Jan. 9th. LumiraDx shares dipped 30.5% to $0.0239 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Harpoon Therapeutics, Inc.(NASDAQ: HARP) gained 98.6% to $20.95 in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share. Vincerx Pharma, Inc. (NASDAQ: VINC) shares rose 56.3% to $1.86 in pre-market trading after the company announced compelling clinical efficacy of enitociclib in combination with venetoclax and prednisone in lymphoma. Spectaire Holdings Inc. (NASDAQ: SPEC) shares gained 46.6% to $2.48 in pre-market trading after gaining 7% on Friday. Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares gained 36.5% to $3.40 in pre-market trading after jumping over 10% on Friday. Vision Marine Technologies Inc. (NASDAQ:

  Benzinga

  Featured Companies: AIMD BNZI BREA CYCC FTFT HRTX HSCS SGD SPR STSS VMAR
• Interim CEO of Sports Illustrated parent Arena Group steps down, shares tumble

  Arena Group Holdings Inc., the media company that runs Sports Illustrated and TheStreet, said Friday that interim Chief Executive Manoj Bhargava had resigned to steer clear of potential conflicts, and that it had missed some payments and tapped a consulting firm to help shore up its finances.

  MarketWatch